Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.81 USD | +1.09% | -6.34% | -53.48% |
Apr. 08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
Apr. 02 | Leerink Partners Cuts Price Target on Disc Medicine to $65 From $77, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.48% | 655M | |
+2.00% | 42.59B | |
+8.46% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.96% | 24.81B | |
-24.05% | 18.17B | |
+29.27% | 12.05B | |
-2.77% | 11.7B | |
+7.04% | 11.1B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Sector Update: Health Care Stocks Bouncing Back from Earlier Slump